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http:WHAT THIS PAPER ADDS
Arterial stiffness in diabetics may render the ankle-brachial index (ABI) unreliable, even below the guideline
recommended threshold for a falsely elevated ABI of > 1.4. Consequently, the use of the toe-brachial index (TBI)
is advocated in the initial vascular examination of diabetics. However, there is no evidence that the TBI yields
additional information compared with the ABI in diabetic patients if the ABI is not obviously elevated.Objective/Background: Arterial calciﬁcation may render the ankle-brachial index (ABI) unreliable in diabetic
patients. Although guidelines recommend the toe-brachial index (TBI) for patients with falsely elevated ABI
arbitrarily deﬁned as an ABI > 1.4, arterial calciﬁcation is also common among diabetic patients with an ABI 
1.4. This could result in a “falsely normalized” ABI and under-diagnosis of peripheral arterial disease (PAD). We
investigated whether diabetes invalidates the ABI as opposed to the TBI, and if the TBI may therefore be more
suitable for detecting PAD in diabetic patients.
Methods: The difference between ABI and TBI was compared between diabetic and non-diabetic patients with
an ABI  1.4 referred to the vascular laboratory. A BlandeAltman plot was constructed to assess whether ABIe
TBI differences were dependent on the magnitude of the measurements. Subgroup analyses were performed for
patients with a normal ABI, and for patients with critical ischemia.
Results: The population comprised 161 diabetic (252 limbs) and 160 non-diabetic (253 limbs) patients (mean age
67). Median ABIs (0.79 vs. 0.80) were similar, while median TBI was 0.07 higher in diabetics (p ¼ 0.024). The ABIe
TBI difference in diabetics and non-diabetics was similar (0.32 vs. 0.35; p ¼ .084), and was also similar for
patients with a normal ABI. Moreover, ABIeTBI differences in diabetic- and non-diabetic patients overlapped,
irrespective of the magnitude of the measurements. Diabetes was not associated with larger differences between
ankle and toe pressures (mean difference 0.9 mmHg, 95% conﬁdence interval 15 to 13 mmHg) among
patients with critical ischemia.
Conclusion: No evidence was found that the TBI may overcome the potentially invalidated ABI in diabetic
patients with an ABI  1.4. ABI and TBI are strongly associated, and this relationship is not inﬂuenced by
diabetes. Therefore, the TBI does not allow for earlier detection of ischemia in diabetes.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Background
Lower extremity peripheral arterial disease (PAD) ranges in
severity from asymptomatic to critical limb ischemia with
tissue loss. Early detection of PAD is crucial, not only to
provide symptomatic patients with adequate therapy, but
also to guide the intensity of secondary prevention for
these patients, who are at high risk of subsequentresponding author.
il address: r.m.stoekenbroek@amc.uva.nl (R.M. Stoekenbroek).
-5884/$ e see front matter  2014 European Society for Vascular
. Published by Elsevier Ltd. All rights reserved.
//dx.doi.org/10.1016/j.ejvs.2014.10.020cardiovascular (CV) morbidity and mortality.1,2 PAD is
particularly common among patients with diabetes, who
have more severe disease and worse outcomes than those
without diabetes.2,3 The ankle-brachial index (ABI) is widely
recommended in the initial assessment of lower extremity
perfusion, based on a substantial body of evidence linking
low ABI to imaging-conﬁrmed PAD, and increased CV
morbidity and mortality.4 However, the sensitivity of the ABI
may be lower in diabetic patients, presumably as a result of
the high prevalence of medial arterial calciﬁcation (MAC)
and the resulting arterial stiffening.5e9 Clinical guidelines
recognize that the ABI may be unreliable in diabetic patients
and recommend alternative tests, such as the toe-brachial
index (TBI) for patients suspected of having a falsely
elevated ABI. The threshold for a falsely elevated ABI is
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frequently observed in the ankle arteries of patients with an
ABI below this threshold, and imaging-conﬁrmed arterial
stenosis is common among diabetic patients with an ABI
within the normal reference range.8,10e14 Based on the
assumption that the toe arteries are less susceptible to
MAC, it is frequently suggested that assessment of the TBI
in addition to the ABI may enable earlier detection of PAD
in the initial vascular examination of diabetic patients, even
when the ABI is not obviously falsely elevated.8,10e14
Objectives
The aim of the study was to investigate if the ABI un-
derestimates the severity of ischaemia in diabetic patients,
even below the recommended threshold for falsely elevated
pressures of 1.4, and whether it is useful to include assess-
ment of the TBI in the initial vascular examination of diabetic
patients. The difference between the ABI and the TBI was
therefore compared between diabetic and non-diabetic pa-
tients, for whom the ABI has been validated, in a population
with suspected PAD referred to the vascular laboratory.
METHODS
Design
A retrospective cross-sectional study was performed to
compare the differences between the ABI and TBI among
diabetic and non-diabetic patients referred to the vascular
laboratory of the Academic Medical Center (AMC),
Amsterdam, the Netherlands, for a non-invasive vascular
examination of the lower extremities. The current article
was written in accordance with the STROBE statement for
cross-sectional studies, which is a checklist to ensure ac-
curate and complete conduct and reporting of observa-
tional studies.15 Ethical approval from the local institutional
review board is not necessary for retrospective chart
reviews.
Patient selection. The vascular laboratory of the AMC
serves as the primary diagnostic unit for non-invasive
vascular examination for all in- and outpatients at the ter-
tiary hospital. A sample of consecutive patients referred for
non-invasive vascular examination was taken from the
10,464 measurements performed between 1993 and 2005.
Patients were included if ankle, toe, and brachial blood
pressures were simultaneously obtained during a single
visit, irrespective of other characteristics, to assure that the
sample reﬂected the population referred to the vascular
laboratory. Patients with acute limb ischemia were
excluded, as were patients with unknown diabetes status,
an ABI > 1.4, or measurement results deemed unreliable by
the vascular technician owing to the inability to comply
with the measurement protocol. Patients were identiﬁed
using unique identifying numbers, and only the ﬁrst mea-
surement was included.
As this was an exploratory study, the sample size required
to detect a clinically relevant difference in ABIeTBI between
diabetic and non-diabetic patients could only be estimatedtentatively. A study by Brooks et al. reported an ABIeTBI
difference for diabetic patients of 0.37, with an SD of 0.15.16
Including 222 measurements in the diabetic and in the non-
diabetic group provides 80% power to detect a 10% dif-
ference in the mean ABIeTBI between diabetic and non-
diabetic patients at a two-sided signiﬁcance level of 0.05.
A margin of 15% was taken to improve the statistical power,
and data on 505 measurements were included.
Measurements. Experienced vascular technicians from the
vascular laboratory at the AMC carried out all measure-
ments. Great toe blood pressures were obtained using a
photoplethysmograph (Nicolet VasoGuard; VIASYS Health-
care, Madison, WI, USA). Ankle systolic blood pressures
(SBPs) in both the posterior tibial and the dorsalis pedis
arteries were obtained using a Doppler device (Nicolet
VasoGuard; VIASYS Healthcare). Prior to 2005, ankle SBPs
were measured using an 8-MHz Doppler probe (Stöpler; PV
Lab, Electronic Diagnostic Instruments, Burbank, CA, USA)
and a 12-cm cuff just proximal to the ankle, and toe SBPs
were measured by photoplethysmography (Stöpler; PV Lab)
and a digital cuff with a width depending on the diameter of
the toe (1.9 or 2.5 cm). The ABI and TBI were calculated by
dividing the highest systolic ankle or toe blood pressure by
the highest of both systolic brachial artery blood pressures.
For the ABI, values between 0.91 and 1.4 were considered
within the normal range.
All measurement results and baseline characteristics
were documented on examination and subsequently vali-
dated by checking the medical charts. A patient was
considered to have diabetes or hypertension if this was
documented in the patient chart, or if the patient was
prescribed antidiabetic or antihypertensive drugs, respec-
tively. Smoking was deﬁned as smoking within the last 5
years, or a history of > 15 pack years. End stage renal
disease, deﬁned as dialysis dependence or history of kidney
transplantation, and clinical disease stage (i.e., asymptom-
atic, intermittent claudication, rest pain, or tissue loss),
were considered potential effect modiﬁers. Age at exami-
nation was considered a potential confounder as it is a
known predictor of arterial calciﬁcation and may be inﬂu-
enced by the presence of diabetes.17
Statistical methods
Continuous values were expressed as means and SD, or
medians and interquartile ranges, where appropriate.
Baseline characteristics of diabetic and non-diabetic pa-
tients were displayed as differences with 95% conﬁdence
intervals (CIs) and analyzed statistically using chi-square
tests or two-sampled Student t tests/ManneWhitney U
tests, depending on the normality of the data.
Limbs were used as the unit of analysis. The ABIeTBI
difference was compared between diabetic and non-
diabetic patients using a Student t test. A BlandeAltman
plot was constructed to assess whether the difference be-
tween the ABI and TBI was dependent on the magnitude of
the pressure values for diabetic and non-diabetic patients.
Lines for the 95% limits of agreement were constructed
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patients, for whom the ABI has been extensively validated
and who therefore served as the reference group.
Two subgroup analyses were performed. The ﬁrst was for
patients with an ABI between 0.91 and 1.4, to compare the
differences between ABI and TBI for diabetic and non-
diabetic patients who would currently not be recognized
as having PAD. The other subgroup included only patients
with ischemic rest pain or tissue loss, and the difference
between absolute ankle- and toe pressures rather than the
ABIeTBI difference was compared. If age was unevenly
distributed, an additional subgroup analysis would be per-
formed for patients aged 50e65 years.
p < .05 was considered statistically signiﬁcant. Statistical
analyses were performed using SPSS version 20.0 (IBM
Statistics, Armonk, NY, USA).
RESULTS
Baseline characteristics
Baseline characteristics for the 161 diabetic patients (252
limbs) and 160 non-diabetic patients (253 limbs) are shown
in Table 1. Notably, age and sex were equally distributed
between both groups, whereas hypertension was more
common among diabetics and (history of) smoking among
non-diabetics. Moreover, diabetic patients more often
presented with tissue loss. The majority of diabetic patients
(77%) had type 2 diabetes (Table 1). Approximately half ofTable 1. Baseline characteristics.
Variable DMþ
n 252
Sex, male (%) 31.0
Age, y (mean  SD) 68  13
Hypertension (%) 82.0
Unknown 2.7
ESRD (%) 7.9
Smoking (%) 39
Unknown 12.0
Previous vascular intervention (%) 16
Clinical disease stage (%)
No symptoms 26.0
Intermittent claudication 19.0
Rest pain 6.7
Tissue loss 25.0
Unknown 23.0
DM characteristics
Type 1 7.9
Type 2 77.0
Unknown type 15.0
IDDM 46.0
NIDDM 51.0
Unknown 3.0
Duration of DM (median þ IQR) 11.0
ABI
 0.90 60.0
0.91e1.40 41.0
Note. DM ¼ diabetes mellitus; DMþ ¼ DM positive; DMe ¼ DM ne
IDDM ¼ insulin dependent diabetes mellitus; NIDDM ¼ non-insuli
ankle-brachial index; NA ¼ not applicable.diabetic patients used insulin, and the median duration of
diabetes was 11 years. The proportion of men was some-
what higher among patients with an ABI  0.9 than among
patients with an ABI > 0.9 (35% vs. 25%).Pressure measurements
Median ABI values did not differ between diabetic and non-
diabetic patients, while diabetic patients had a signiﬁcantly
higher median TBI value (Table 2). Consequently, the mean
difference ABIeTBI tended to be smaller in diabetic pa-
tients, although the difference between both groups was
not statistically signiﬁcant.
In the subgroup of patients with an ABI within the normal
range (0.91e1.4), neither the ABI and TBI nor the difference
between the two signiﬁcantly differed between diabetic
and non-diabetic patients (Table 2). The differences be-
tween ABI and TBI according to clinical disease stage are
given in Table 3. Among patients with rest pain or tissue
loss, no signiﬁcant differences were found in the absolute
ankle and toe pressures between diabetic and non-diabetic
patients (mean difference 0.9 mmHg, 95% CI e15 to
13 mmHg; p ¼ .897) (Fig. 1).
The BlandeAltman plot shows that the ABI values were
systematically higher (0.32) than the TBI values across the
range of measurements (Fig. 2). Overall, ABIeTBI differ-
ences were large: 95% of these differences were between
0.00 (i.e., TBI ¼ ABI) and 0.76 (i.e. ABI > TBI). The observedDMe Difference 95% CI
253
31 0.5 0.076 to 0.086
66  15 1.4 0.971 to 3.814
54.0 28.0 0.202e0.358
6.3 3.5 0.072 to 0.001
5.1 2.8 0.015 to 0.071
58 18.4 0.270 to 0.098
11.0 0.8 0.047 to 0.063
24 8.2 0.152 to 0.013
34.0 8.2 0.162 to 0.002
27.0 8.6 0.160 to 0.013
10.0 3.5 0.084 to 0.014
11.0 14.0 0.077e0.210
17.0 6.0 0.010 to 0.131
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
59.0 0.6 0.080 to 0.093
40.0 0.6 0.093 to 0.080
gative; CI ¼ conﬁdence interval; ESRD ¼ end stage renal disease;
n dependent diabetes mellitus; IQR ¼ interquartile range; ABI,
Table 2. Measurement results and difference ankle-brachial index (ABI)etoe-brachial index (TBI).
Variable Overall ABI 0.91e1.40
DMþ DMe p DMþ DMe p
Median ABI (IQR) 0.79 (0.50) 0.80 (0.59) .582a 1.06 (0.15) 1.07 (0.16) .259a
Median TBI (IQR) 0.44 (0.38) 0.37 (0.47) .024a 0.64 (0.29) 0.66 (0.30) .904a
Mean difference ABIeTBI (SD) 0.32 (0.24) 0.35 (0.23) .084b 0.43 (0.24) 0.45 (0.26) .484b
Note. DM ¼ diabetes mellitus; DMþ ¼ DM positive; DMe ¼ DM negative; IQR ¼ interquartile range.
a ManneWhitney U test.
b Student t test.
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diabetic patients was largely independent of the magnitude
of the measurements. Moreover, nearly all of the ABIeTBI
differences of diabetic patients fell within the reference
range formed by the 95% limits of agreement based on the
measurements in non-diabetic patients.
The ABIeTBI difference was independent of sex in the
overall group (mean difference between men and women:
0.014; 95% CI e0.030 to 0.059), as well as in patients with
an ABI between 0.9 and 1.4 (mean difference between men
and women: 0.074; 95% CI e0.004 to 0.151).
DISCUSSION
This study shows that diabetic patients, compared with
patients without diabetes, with an ABI  1.4 do not have a
lower TBI at similar ABIs. This ﬁnding was irrespective of the
magnitude of the pressure measurements. Likewise, the
difference between absolute ankle and toe pressures was
similar between diabetics and non-diabetics with rest pain
or tissue loss. Therefore, the hypothesis that diabetes in-
validates the ABI as opposed to the TBI even below the
guideline recommended threshold for falsely elevated ABIs
of 1.4 was not conﬁrmed.
It is widely assumed that MAC, also known as Möncke-
berg’s sclerosis, is responsible for the falsely elevated ABI
frequently encountered among diabetic patients.18 MAC is
particularly common among diabetic patients and results in
stiffening of the arterial wall, thereby increasing theTable 3. Measurement results and differences for each clinical disease
No symptoms Intermittent c
DMþ DMe DMþ D
n ¼ 65 n ¼ 86 n ¼ 47 n
ABI, median (IQR) 1.03 (0.24) 1.03 (0.25) 0.63 (0.32) 0
TBI, median (IQR) 0.61 (0.29) 0.67 (0.35) 0.38 (0.26) 0
Mean  SD difference
ABIeTBI
0.37  0.23 0.40  0.25 0.23  0.22 0
Highest absolute ankle
blood pressure (mmHg),
median (IQR)
152 (42) 158 (49) 114 (43) 8
Absolute toe blood
pressure (mmHg),
median (IQR)
95 (50) 94 (49) 62 (50) 3
Mean difference ankle-toe
blood pressure (mmHg),
mean (SD)
56 (36) 61 (40) 36 (35) 4
Note. DM ¼ diabetes mellitus; DMþ ¼ DM positive; DMe ¼ DM
TBI ¼ toe-brachial index.pressure required for compression of the ankle arteries,
which may falsely elevate the ABI.8 Aside from diabetes, an
association has been demonstrated between MAC and pe-
ripheral neuropathy, male sex, advancing age, renal insuf-
ﬁciency, and genetic factors.19,20
Several explanations may account for the observed lack
of divergence between the ABI and TBI in diabetic patients
in this study. First, it is possible that in diabetic patients
with an ABI  1.4 the ankle vessels are not stiffened to a
degree that would falsely elevate the ABI. However, several
studies have indicated a high prevalence of MAC among
diabetic patients with an ABI  1.4, and increased arterial
stiffness can be observed even among pre-diabetic patients,
in whom severe MAC is less likely.5,7,21 Second, the
recommendation that the TBI may be more sensitive for the
detection of limb ischemia is based on the assumption that
the toe arteries are less susceptible to MAC. However, this
assumption is largely based on a single study in which a
declining gradient of the prevalence of MAC from the ankle
vessels to the toe vessels was observed on plain radio-
graphs.14 Plain X-rays may have limited sensitivity for
detecting calciﬁcation of the toe arteries, and calciﬁcation
of the toe arteries was still observed in 24e40% of diabetic
patients with neuropathy. Third, it has been suggested that
the distal distribution of atherosclerosis in diabetic patients
may partially contribute to the unreliability of the ABI in
diabetic patients.22 At least in theory, very distally located
lesions could cause signiﬁcant ischemia of parts of the foot,stage.
laudication Rest pain Tissue loss
Me DMþ DMe DMþ DMe
¼ 69 n ¼ 17 n ¼ 26 n ¼ 64 n ¼ 28
.52 (0.34) 0.54 (0.61) 0.42 (0.46) 0.69 (0.51) 0.49 (0.31)
.24 (0.27) 0.26 (0.47) 0.00 (0.19) 0.29 (0.43) 0.18 (0.28)
.29  0.20 0.18  0.24 0.37  0.34 0.37  0.23 0.31  0.18
3 (54) 86 (88) 66 (58) 101 (88) 81 (54)
5 (40) 33 (61) 0 (31) 45 (49) 28 (34)
6 (32) 28 (37) 57 (51) 60 (39) 52 (31)
negative; ABI ¼ ankle-brachial index; IQR ¼ interquartile range;
Figure 2. BlandeAltman plot of ankle-brachial index (ABI) and toe-
brachial index (TBI). Note. Reference lines are the mean ABIeTBI
difference and 95% limits of agreement obtained from non-
diabetic patients. The line of straight measurements in the upper
left side of the plot depicts patients with no detectable toe
pressure despite measurable ankle pressure.Figure 1. Ankle-brachial index (ABI) versus toe-brachial index (TBI).
Note. Green triangles indicate diabetic patients, blue circles indi-
cate non-diabetic patients.
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ent. In addition, the limited reproducibility of ankle and toe
pressure measurements could mask a potential association
between diabetes and ABIeTBI differences.23
If the lack of divergence between ABI and TBI in diabetics
as found in our study could be explained by either falsely
elevated TBI or distally located lesions, then both measures
would underestimate the true extent of ischemia and one
would expect higher readings of both measurements at
similar clinical stages in diabetic patients compared with
non-diabetics. Indeed, diabetic patients were characterized
by a slightly higher ABI and TBI than non-diabetics at each
clinical disease stage (Table 3).
The present ﬁndings as to the non-divergence of ABI and
TBI in diabetic patients with an ABI  1.4 are in line with
previous studies.16,24e26 However, those studies did not
include patients referred to the vascular laboratory, or they
only reported the overall correlation between the ABI and
TBI for diabetic and non-diabetic patients. Several other
studies have reported on the agreement between the TBI
and ABI in categorizing patients according to PAD status
using a variety of diagnostic limits for the TBI, with different
conclusions on the additional value of the TBI.11,13,16,25e28
The various cut off values for the TBI used in these
studies reﬂect the lack of agreement on the optimal diag-
nostic limits in diagnosing PAD.29
In the current study, the TBI and the ABI were used,
rather than the absolute systolic blood pressures, to allow
categorization of patients into PAD categories, as recom-
mended by clinical guidelines using the ABI, and to accountfor possible differences in the prevalence of hypertension
between diabetic and non-diabetic patients. However, for
patients with rest pain or tissue loss, the differences in
absolute ankle and toe blood pressures were compared, as
guidelines recommend the use of absolute pressures in
these patients. Diagnostic limits of 50 mmHg for the ankle
blood pressure and 30 mmHg for the toe blood pressure
have been shown to predict wound healing in patients with
tissue loss. Our results indicate that among patients with an
ABI  1.4, the ABIeTBI differences between diabetics and
non-diabetics did not change substantially across the range
of ankle and toe pressures. The present study did not
include patients with an ABI > 1.4, as the high likelihood of
a falsely elevated ABI and the high prevalence of PAD
among these patients mandates additional tests, irre-
spective of the presence of diabetes.27,30 Although a num-
ber of studies have indicated that the TBI may provide a
more adequate estimate of limb ischemia in these patients,
its sensitivity for detecting PAD remains to be
established.26,29,30
A number of limitations of the current study should be
taken into consideration. As data were obtained in clinical
practice, missing data and coding imperfections could have
limited the reliability of the results. However, data were
prospectively documented and could be validated using the
patients’ medical charts. Yet, it was not possible to take into
account all known predictors of MAC, perhaps most
importantly the presence of neuropathy. Hence, the possi-
bility that the conclusions are not applicable to patients
with severe neuropathy cannot be excluded. In addition, the
severity of MAC is likely to depend on glycemic control and
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account glycemic control. The sample size in the present
study was insufﬁcient to reliably determine whether the
similarity in the ABIeTBI difference between diabetic and
non-diabetic patients is dependent on the duration of dia-
betes. The high proportion of women in the study popula-
tion cannot be accounted for. However, no apparent
discrepancies in ABIeTBI differences were found between
men and women in the overall group or within the group of
patients with an ABI within the normal reference range. In
addition, the sex distribution was not different for diabetic
and non-diabetic patients. Considering that the purpose of
the study was to assess whether the TBI might overcome
potentially ﬂawed ABIs in diabetic patients, imaging studies
were not performed. Therefore, it was not possible to
assess the diagnostic accuracy of ABI or TBI for the
assessment of PAD.
Implications for practice and further studies
The ﬁndings of this study indicate that diabetes does not
falsify the ABI any more than the TBI in patients with an ABI
 1.4. As such, the TBI is not capable of overcoming the
potentially invalidated results of the ABI in diabetic patients
with an ABI  1.4, and the widely held belief that assess-
ment of the TBI in the initial vascular examination of dia-
betic patients may allow for earlier detection of PAD is not
valid. Although the TBI is widely used, and its application is
recommended by clinical guidelines, more research is
needed to validate the TBI against imaging-conﬁrmed PAD,
and the optimal cut-off values remain to be established.
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